[HTML][HTML] Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)

M Rizzo, A Colletti, PE Penson, N Katsiki… - Pharmacological …, 2023 - Elsevier
Abstract Non-Alcoholic Fatty Liver Disease (NAFLD) is a common condition affecting around
10–25% of the general adult population, 15% of children, and even> 50% of individuals who …

[PDF][PDF] Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)

M Rizzo, A Colletti, PE Penson, N Katsiki… - Pharmacological …, 2023 - researchgate.net
ABSTRACT Non-Alcoholic Fatty Liver Disease (NAFLD) is a common condition affecting
around 10–25% of the general adult population, 15% of children, and even> 50% of …

[引用][C] Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)

M Rizzo, A Colletti, PE Penson, N Katsiki… - 2023 - publications.goettingen-research …

[PDF][PDF] Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP) http://researchonline …

M Rizzo, A Colletti, PE Penson, N Katsiki… - core.ac.uk
ABSTRACT Non-Alcoholic Fatty Liver Disease (NAFLD) is a common condition affecting
around 10–25% of the general adult population, 15% of children, and even> 50% of …

Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP).

M Rizzo, A Colletti, PE Penson, N Katsiki… - Pharmacological …, 2023 - europepmc.org
Non-Alcoholic Fatty Liver Disease (NAFLD) is a common condition affecting around 10-25%
of the general adult population, 15% of children, and even> 50% of individuals who have …

Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)

M Rizzo, A Colletti, PE Penson… - Pharmacological …, 2023 - publicum.umed.lodz.pl
Non-Alcoholic Fatty Liver Disease (NAFLD) is a common condition affecting around 10-25%
of the general adult population, 15% of children, and even> 50% of individuals who have …

Nutraceutical approaches to Non-Alcoholic Fatty Liver Disease (NAFLD): a position paper from the international lipid expert panel (ILEP).

M Rizzo, A Colletti, PE Penson, N Katsiki… - 2023 - cabidigitallibrary.org
Abstract Non-Alcoholic Fatty Liver Disease (NAFLD) is a common condition affecting around
10-25% of the general adult population, 15% of children, and even> 50% of individuals who …

Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)

M Rizzo, A Colletti, P Penson, N Katsiki… - PHARMACOLOGICAL …, 2023 - cris.unibo.it
Abstract Non-Alcoholic Fatty Liver Disease (NAFLD) is a common condition affecting around
10-25% of the general adult population, 15% of children, and even> 50% of individuals who …

Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)

M Rizzo, A Colletti, PE Penson… - Pharmacological …, 2023 - researchonline.ljmu.ac.uk
Non-Alcoholic Fatty Liver Disease (NAFLD) is a common condition affecting around 10–25%
of the general adult population, 15% of children, and even> 50% of individuals who have …

Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)

M Rizzo, A Colletti, PE Penson, N Katsiki… - Pharmacological …, 2023 - repo.uni.opole.pl
Non-Alcoholic Fatty Liver Disease (NAFLD) is a common condition affecting around 10–25%
of the general adult population, 15% of children, and even> 50% of individuals who have …